These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19200818)

  • 1. Safety experience with heptavalent pneumococcal CRM197-conjugate vaccine (Prevenar) since vaccine introduction.
    Center KJ; Strauss A
    Vaccine; 2009 May; 27(25-26):3281-4. PubMed ID: 19200818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevenar vaccination: review of the global data, 2006.
    Center KJ
    Vaccine; 2007 Apr; 25(16):3085-9. PubMed ID: 17287048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of pneumococcal 7-valent conjugate vaccine (diphtheria CRM(197) protein conjugate; Prevenar ) in Korean infants: differences that are found in Asian children.
    Kim NH; Lee J; Lee SJ; Lee H; Kim KH; Park SE; Lee HJ
    Vaccine; 2007 Nov; 25(45):7858-65. PubMed ID: 17931753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
    Chevallier B; Vesikari T; Brzostek J; Knuf M; Bermal N; Aristegui J; Borys D; Cleerbout J; Lommel P; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S109-18. PubMed ID: 19325447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of 7-valent pneumococcal conjugate vaccine.
    Ghaffar F
    Expert Opin Drug Saf; 2005 Jul; 4(4):631-6. PubMed ID: 16011442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post licensure safety surveillance for Prevenar].
    Bensouda-Grimaldi L; Jonville-Béra AP; Autret-Leca E
    Arch Pediatr; 2007 Jul; 14(7):870-4. PubMed ID: 17442548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).
    Oosterhuis-Kafeja F; Beutels P; Van Damme P
    Vaccine; 2007 Mar; 25(12):2194-212. PubMed ID: 17267077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1148-51. PubMed ID: 18946462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with the 7-valent conjugate pneumococcal vaccine: impact evaluation, continuing surveillance and future perspectives.
    Bechini A; Boccalini S; Bonanni P
    Vaccine; 2009 May; 27(25-26):3285-90. PubMed ID: 19200829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].
    de Greeff SC; Sanders EA; de Melker HE; van der Ende A; Vermeer PE; Schouls LM
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1454-7. PubMed ID: 17633974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands.
    David S; Vermeer-de Bondt PE; van der Maas NA
    Vaccine; 2008 Oct; 26(46):5883-7. PubMed ID: 18775463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatricians' adherence to pneumococcal conjugate vaccine shortage recommendations in 2 national shortages.
    Fairbrother G; Broder K; Staat MA; Schwartz B; Heubi C; Hiratzka S; Walker FJ; Morrow AL
    Pediatrics; 2007 Aug; 120(2):e401-9. PubMed ID: 17646354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-marketing effectiveness of Prevnar [pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein)] and implications for adult immunization.
    Parijs BA; Malinoski FJ
    Mech Ageing Dev; 2004 Feb; 125(2):147-8. PubMed ID: 15037021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants.
    Esposito S; Pugni L; Bosis S; Proto A; Cesati L; Bianchi C; Cimino C; Mosca F; Principi N
    Vaccine; 2005 Feb; 23(14):1703-8. PubMed ID: 15705475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serotype 19F pneumococcal meningitis in an imunocompetent infant immunized with heptavalent pneumococcal conjugated vaccine Prevenar].
    Isapof A; Delacourt C; Reinert P; Cohen R; Madhi F
    Arch Pediatr; 2009 Aug; 16(8):1133-6. PubMed ID: 19500954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association of Kawasaki disease after immunization in a cohort of infants followed for multiple autoimmune diagnoses in a large, phase-4 observational database safety study of 7-valent pneumococcal conjugate vaccine: lack of association between Kawasaki disease and seven-valent pneumococcal conjugate vaccine.
    Center KJ; Hansen JR; Lewis E; Fireman BH; Hilton B
    Pediatr Infect Dis J; 2009 May; 28(5):438-40. PubMed ID: 19319016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Present view of conjugated pneumococcus vaccines].
    Prymula R
    Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):98-102. PubMed ID: 17051470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine.
    Dinleyici EC; Yargic ZA
    Expert Rev Vaccines; 2009 Aug; 8(8):977-86. PubMed ID: 19627181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.